edoc

Items where Author is "Kappos, L."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2022 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1995
Number of items: 126.

2022

Hardmeier, M. and Schlaeger, R. and Lascano, A. M. and Toffolet, L. and Schindler, C. and Gobbi, C. and Lalive, P. and Kuhle, J. and Kappos, L. and Fuhr, P.. (2022) Prognostic biomarkers in primary progressive multiple sclerosis: validating and scrutinizing multimodal evoked potentials. Clinical neurophysiology, 137. pp. 152-158.

2019

Tsagkas, C. and Horvath, A. and Altermatt, A. and Pezold, S. and Weigel, M. and Haas, T. and Amann, M. and Kappos, L. and Sprenger, T. and Bieri, O. and Cattin, P. and Parmar, K.. (2019) Automatic Spinal Cord Gray Matter Quantification: A Novel Approach. American journal of neuroradiology. n.a..

2016

Rasenack, M. and Rychen, J. and Andelova, M. and Naegelin, Y. and Stippich, C. and Kappos, L. and Lindberg, R. L. and Sprenger, T. and Derfuss, T.. (2016) Efficacy and Safety of Fingolimod in an Unselected Patient Population. PLoS One, 11 (1). e0146190.

Havla, J. and Warnke, C. and Derfuss, T. and Kappos, L. and Hartung, H. P. and Hohlfeld, R.. (2016) Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis. Deutsches Ärzteblatt international , 113 (51-52). pp. 879-886.

Probstel, A. K. and Schaller, A. and Lieb, J. and Hench, J. and Frank, S. and Fuhr, P. and Kappos, L. and Sinnreich, M.. (2016) Mitochondrial cytopathy with common MELAS mutation presenting as multiple system atrophy mimic. Neurol Genet, 2 (6). e121.

Probstel, A. K. and Kuhle, J. and Lecourt, A. C. and Vock, I. and Sanderson, N. S. and Kappos, L. and Derfuss, T.. (2016) Multiple Sclerosis and Antibodies against KIR4.1. N Engl J Med, 374 (15). pp. 1496-1498.

Kappos, L. and Arnold, D. L. and Bar-Or, A. and Camm, J. and Derfuss, T. and Kieseier, B. C. and Sprenger, T. and Greenough, K. and Ni, P. and Harada, T.. (2016) Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet Neurology, 15 (11). pp. 1148-1159.

Rust, H. and Kuhle, J. and Kappos, L. and Derfuss, T.. (2016) Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy. Neurology: Neuroimmunology & Neuroinflammation, 3 (2). e215.

Disanto, G. and Benkert, P. and Lorscheider, J. and Mueller, S. and Vehoff, J. and Zecca, C. and Ramseier, S. and Achtnichts, L. and Findling, O. and Nedeltchev, K. and Radue, E. W. and Sprenger, T. and Stippich, C. and Derfuss, T. and Louvion, J. F. and Kamm, C. P. and Mattle, H. P. and Lotter, C. and Du Pasquier, R. and Schluep, M. and Pot, C. and Lalive, P. H. and Yaldizli, O. and Gobbi, C. and Kappos, L. and Kuhle, J. and Smsc Scientific Board, . (2016) The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS One, 11 (3). e0152347.

Diebold, M. and Kappos, L. and Derfuss, T.. (2016) Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen. Nervenarzt, 87 (8). pp. 814-820.

2015

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Multiple Sclerosis Journal, 21 (7). pp. 885-893.

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up. Journal of Neuroimmunology, 285. pp. 68-70.

Hubacher, M. and Kappos, L. and Weier, K. and Stöcklin, M. and Opwis, K. and Penner, I. -K.. (2015) Case-based fMRI analysis after cognitive rehabilitation in MS: A novel approach. Frontiers in Neurology, 6. p. 78.

Hubacher, M. and Kappos, L. and Weier, K. and Stöcklin, M. and Opwis, K. and Penner, I. -K.. (2015) Cognitive rehabilitation of working memory in juvenile Multiple Sclerosis: Effects on cognitive functioning, functional MIRI and network related connectiviy. Restorative Neurology and Neuroscience, 33. pp. 713-725.

Kuhle, J. and Disanto, G. and Dobson, R. and Adiutori, R. and Bianchi, L. and Topping, J. and Bestwick, J. P. and Meier, U. C. and Marta, M. and Dalla Costa, G. and Runia, T. and Evdoshenko, E. and Lazareva, N. and Thouvenot, E. and Iaffaldano, P. and Direnzo, V. and Khademi, M. and Piehl, F. and Comabella, M. and Sombekke, M. and Killestein, J. and Hegen, H. and Rauch, S. and D'Alfonso, S. and Alvarez-Cermeno, J. C. and Kleinova, P. and Horakova, D. and Roesler, R. and Lauda, F. and Llufriu, S. and Avsar, T. and Uygunoglu, U. and Altintas, A. and Saip, S. and Menge, T. and Rajda, C. and Bergamaschi, R. and Moll, N. and Khalil, M. and Marignier, R. and Dujmovic, I. and Larsson, H. and Malmestrom, C. and Scarpini, E. and Fenoglio, C. and Wergeland, S. and Laroni, A. and Annibali, V. and Romano, S. and Martinez, A. D. and Carra, A. and Salvetti, M. and Uccelli, A. and Torkildsen, O. and Myhr, K. M. and Galimberti, D. and Rejdak, K. and Lycke, J. and Frederiksen, J. L. and Drulovic, J. and Confavreux, C. and Brassat, D. and Enzinger, C. and Fuchs, S. and Bosca, I. and Pelletier, J. and Picard, C. and Colombo, E. and Franciotta, D. and Derfuss, T. and Lindberg, R. and Yaldizli, O. and Vecsei, L. and Kieseier, B. C. and Hartung, H. P. and Villoslada, P. and Siva, A. and Saiz, A. and Tumani, H. and Havrdova, E. and Villar, L. M. and Leone, M. and Barizzone, N. and Deisenhammer, F. and Teunissen, C. and Montalban, X. and Tintore, M. and Olsson, T. and Trojano, M. and Lehmann, S. and Castelnovo, G. and Lapin, S. and Hintzen, R. and Kappos, L. and Furlan, R. and Martinelli, V. and Comi, G. and Ramagopalan, S. V. and Giovannoni, G.. (2015) Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis Journal, 21 (8). pp. 1013-1024.

Matsushita, T. and Madireddy, L. and Sprenger, T. and Khankhanian, P. and Magon, S. and Naegelin, Y. and Caverzasi, E. and Lindberg, R. L. and Kappos, L. and Hauser, S. L. and Oksenberg, J. R. and Henry, R. and Pelletier, D. and Baranzini, S. E.. (2015) Genetic associations with brain cortical thickness in multiple sclerosis. Genes, Brain and Behavior, 14 (2). pp. 217-227.

Kappos, L. and Mehling, M. and Arroyo, R. and Izquierdo, G. and Selmaj, K. and Curovic-Perisic, V. and Keil, A. and Bijarnia, M. and Singh, A. and von Rosenstiel, P.. (2015) Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis. Neurology, 84 (9). pp. 872-879.

Mehling, M. and Burgener, A. V. and Brinkmann, V. and Bantug, G. R. and Dimeloe, S. and Hoenger, G. and Kappos, L. and Hess, C.. (2015) Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade. Scandinavian Journal of Immunology, 82 (5). pp. 460-466.

2014

Papadopoulou, A. and Menegola, M. and Kuhle, J. and Ramagopalan, S. V. and D'Souza, M. and Sprenger, T. and Radue, E. W. and Kappos, L. and Yaldizli, O.. (2014) Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 20 (3). pp. 322-330.

Schlaeger, R. and D'Souza, M. and Schindler, C. and Grize, L. and Kappos, L. and Fuhr, P.. (2014) Prediction of MS disability by multimodal evoked potentials : investigation during relapse or in the relapse-free interval? Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, Vol. 125, H. 9. pp. 1889-1892.

Yaldizli, O. and Penner, I. K. and Frontzek, K. and Naegelin, Y. and Amann, M. and Papadopoulou, A. and Sprenger, T. and Kuhle, J. and Calabrese, P. and Radu, E. W. and Kappos, L. and Gass, A.. (2014) The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Multiple Sclerosis Journal, 20 (3). pp. 356-364.

2013

Kuhle, J. and Plattner, K. and Bestwick, J. P. and Lindberg, R. L. and Ramagopalan, S. V. and Norgren, N. and Nissim, A. and Malaspina, A. and Leppert, D. and Giovannoni, G. and Kappos, L.. (2013) A comparative study of CSF neurofilament light and heavy chain protein in MS. Multiple Sclerosis Journal, 19 (12). pp. 1597-1603.

Corporaal, S. H. and Gensicke, H. and Kuhle, J. and Kappos, L. and Allum, J. H. and Yaldizli, O.. (2013) Balance control in multiple sclerosis : correlations of trunk sway during stance and gait tests with disease severity. Gait & posture, Vol. 37, H. 1. pp. 55-60.

Weier, K. and Pezold, S. and Andelova, M. and Amann, M. and Magon, S. and Naegelin, Y. and Radue, E. W. and Stippich, C. and Gass, A. and Kappos, L. and Cattin, Ph. and Sprenger, T.. (2013) Both spinal cord volume and spinal cord lesions impact physical disability in multiple sclerosis. Multiple Sclerosis Journal, 19 (11_suppl). pp. 188-189.

Hubacher, M. and Weber, P. and Stoecklin, M. and Specht, K. and Kappos, L. and Opwis, K. and Penner, I.-K.. (2013) Case-based approach to evaluate the efficacy of working memory training in juvenile Multiple Sclerosis. Multiple Sclerosis Journal, 19 (7). pp. 975-976.

Mehling, M. and Brinkmann, V. and Burgener, A. V. and Gubser, P. and Luster, A. D. and Kappos, L. and Hess, C.. (2013) Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade. Journal of allergy and clinical immunology, Vol. 131, H. 5 , S. 1440-1443 e7.

Gaiottino, J. and Norgren, N. and Dobson, R. and Topping, J. and Nissim, A. and Malaspina, A. and Bestwick, J. P. and Monsch, A. U. and Regeniter, A. and Lindberg, R. L. and Kappos, L. and Leppert, D. and Petzold, A. and Giovannoni, G. and Kuhle, J.. (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE, Vol. 8, H. 9 , e75091.

Derfuss, T. and Kuhle, J. and Lindberg, R. and Kappos, L.. (2013) Natalizumab therapy for multiple sclerosis. Seminars in neurology, Vol. 33, H. 1. pp. 26-36.

Kuhle, J. and Malmestrom, C. and Axelsson, M. and Plattner, K. and Yaldizli, O. and Derfuss, T. and Giovannoni, G. and Kappos, L. and Lycke, J.. (2013) Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Acta neurologica scandinavica, Vol. 128, H. 6 , e33-36.

Derfuss, T. and Kappos, L.. (2013) Predicting PML in natalizumab-treated patients: can we do better? Journal of neurology, neurosurgery, and psychiatry, Vol. 84, H. 11. pp. 1182-1183.

Mehling, M. and Fritz, S. and Hafner, P. and Eichin, D. and Yonekawa, T. and Klimkait, T. and Lindberg, R. L. and Kappos, L. and Hess, C.. (2013) Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNbeta-Therapy. PLoS ONE, Vol. 8, H. 11 , e78532.

Ozcelik, S. and Fraser, G. and Castets, P. and Schaeffer, V. and Skachokova, Z. and Breu, K. and Clavaguera, F. and Sinnreich, M. and Kappos, L. and Goedert, M. and Tolnay, M. and Winkler, D. T.. (2013) Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS ONE, Vol. 8, H. 5 , e62459.

Ricklin, M. E. and Lorscheider, J. and Waschbisch, A. and Paroz, C. and Mehta, S. K. and Pierson, D. L. and Kuhle, J. and Fischer-Barnicol, B. and Sprenger, T. and Lindberg, R. L. and Kappos, L. and Derfuss, T.. (2013) T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology, Vol. 81, H. 2. pp. 174-181.

2012

Sievers, C. and Meira, M. and Hoffmann, F. and Fontoura, P. and Kappos, L. and Lindberg, R. L.. (2012) Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clinical immunology, Vol. 144, H. 1. pp. 70-79.

Schlaeger, R. and D'Souza, M. and Schindler, C. and Grize, L. and Kappos, L. and Fuhr, P.. (2012) Combined evoked potentials as markers and predictors of disability in early multiple sclerosis. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, Vol. 123, H. 2. pp. 406-410.

Derfuss, T. and Kappos, L.. (2012) Evaluating the potential benefit of interferon treatment in multiple sclerosis. JAMA, Vol. 308, H. 3. pp. 290-291.

Weier, K. and Beck, A. and Magon, S. and Amann, M. and Naegelin, Y. and Penner, I. K. and Thurling, M. and Aurich, V. and Derfuss, T. and Radue, E. W. and Stippich, C. and Kappos, L. and Timmann, D. and Sprenger, T.. (2012) Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis. Journal of neurology, Vol. 259, H. 12. pp. 2673-2680.

Gensicke, H. and Leppert, D. and Yaldizli, O. and Lindberg, R. L. and Mehling, M. and Kappos, L. and Kuhle, J.. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs, 26 (1). pp. 11-37.

Schlaeger, R. and D'Souza, M. and Schindler, C. and Grize, L. and Dellas, S. and Radue, E. and Kappos, L. and Fuhr, P.. (2012) Prediction of long-term disability in multiple sclerosis. Multiple Sclerosis Journal, 18 (1). pp. 31-38.

Fanchamps, M. H. and Gensicke, H. and Kuhle, J. and Kappos, L. and Allum, J. H. and Yaldizli, O.. (2012) Screening for balance disorders in mildly affected multiple sclerosis patients. Journal of neurology, Vol. 259, H. 7. pp. 1413-1419.

2011

Bush, W. S. and McCauley, J. L. and DeJager, P. L. and Dudek, S. M. and Hafler, D. A. and Gibson, R. A. and Matthews, P. M. and Kappos, L. and Naegelin, Y. and Polman, C. H. and Hauser, S. L. and Oksenberg, J. and Haines, J. L. and Ritchie, M. D. and International Multiple Sclerosis Genetics Consortium, . (2011) A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes and immunity, Vol. 12, H. 5. pp. 335-340.

Neidert, S. and Katan, M. and Schuetz, P. and Fluri, F. and Ernst, A. and Bingisser, R. and Kappos, L. and Engelter, S. T. and Steck, A. and Müller, B. and Christ-Crain, M.. (2011) Anterior pituitary axis hormones and outcome in acute ischaemic stroke. Journal of Internal Medicine, 269 (4). pp. 420-432.

Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413.

MacManus, D. G. and Miller, D. H. and Kappos, L. and Gold, R. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Eraksoy, M. and Meluzinova, E. and Dufek, M. and Yang, M. and O'Neill, G. N. and Dawson, K.. (2011) BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. Journal of neurology, Vol. 258, H. 3. pp. 449-456.

Hubacher, M. and Kappos, L. and Opwis, K. and Stoecklin, M. and Weier, K. and Sprenger, T. and Penner, I. -K.. (2011) Benefits of cognitive training in MS patients treated with INFB-1b. Swiss Archives of Neurology and Psychiatry, Jg. 162, Supp. 4. pp. 6-7.

Acaster, S. and Swinburn, P. and Wang, C. and Stemper, B. and Beckmann, K. and Knappertz, V. and Pohl, C. and Sandbrink, R. and Gondek, K. and Edan, G. and Kappos, L. and Freedman, M. and Hartung, H.-P. and Arnason, B. and Comi, G. and Filippi, M. and Jeffery, D. and O'Connor, P. and Cook, S. and Lloyd, A. J.. (2011) Can the functional assessment of multiple sclerosis adapt to changing needs? : a psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 17 (12). pp. 1504-1513.

Hubacher, M. and Kappos, L. and Opwis, K. and Stoecklin, M. and Pape, E. and Penner, I. -K.. (2011) Can treatment effects of IFNB-1b on cognition be enhanced by additional cognitive training? Multiple Sclerosis Journal, 17 (10_suppl). S400-S401.

Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.

Vermersch, P. and Kappos, L. and Gold, R. and Foley, J. F. and Olsson, T. and Cadavid, D. and Bozic, C. and Richman, S.. (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology, Vol. 76, H. 20. pp. 1697-1704.

O'Connor, P. W. and Goodman, A. and Kappos, L. and Lublin, F. D. and Miller, D. H. and Polman, C. and Rudick, R. A. and Aschenbach, W. and Lucas, N.. (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology, Vol. 76, H. 22. pp. 1858-1865.

Waschbisch, A. and Sandbrink, R. and Hartung, H.-P. and Kappos, L. and Schwab, S. and Pohl, C. and Wiendl, H.. (2011) Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology, Vol. 77, H. 6. pp. 596-598.

Rudick, R. A. and Kappos, L. and Kinkel, R. and Clanet, M. and Phillips, J. T. and Herndon, R. M. and Sandrock, A. W. and Munschauer, F. E.. (2011) Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis : analysis of 1406 patients. Multiple Sclerosis Journal, 17 (3). pp. 353-360.

Filippi, M. and Rocca, M. A. and Camesasca, F. and Cook, S. and O'Connor, P. and Arnason, B. G. W. and Kappos, L. and Goodin, D. and Jeffery, D. and Hartung, H.-P. and Comi, G. and Wolinsky, J. S. and Bogumil, T. and Pohl, C. and Beckmann, K. and Sandbrink, R. and Croze, E. and Brown, C. and Desimone, T. M. and Arnold, D. L. and Cutter, G. and Knappertz, V.. (2011) Interferon β-1b and glatiramer acetate effects on permanent black hole evolution. Neurology, Vol. 76, H. 14. pp. 1222-1228.

Hartung, H.-P. and Freedman, M. S. and Polman, C. H. and Edan, G. and Kappos, L. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Petkau, J. and White, R. and Sahajpal, V. and Knappertz, V. and Beckmann, K. and Lanius, V. and Sandbrink, R. and Pohl, C. and Benefit Study Group, . (2011) Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology, Vol. 77, H. 9. pp. 835-843.

Osthoff, M. and Katan, M. and Fluri, F. and Schuetz, P. and Bingisser, R. and Kappos, L. and Steck, A. J. and Engelter, S. T. and Mueller, B. and Christ-Crain, M. and Trendelenburg, M.. (2011) Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS ONE, Vol. 6, H. 6 , e21338.

Kappos, L. and Bates, D. and Edan, G. and Eraksoy, M. and Garcia-Merino, A. and Grigoriadis, N. and Hartung, H. P. and Havrdova, E. and Hillert, J. and Hohlfeld, R. and Kremenchutzky, M. and Lyon-Caen, O. and Miller, A. and Pozzilli, C. and Ravnborg, M. and Saida, T. and Sindic, C. and Vass, K. and Clifford, D. B. and Hauser, S. and Major, E. O. and O'Connor, P. W. and Weiner, H. L. and Clanet, M. and Gold, R. and Hirsch, H. H. and Radu, E. W. and Sorensen, P. S. and King, J.. (2011) Natalizumab treatment for multiple sclerosis : updated recommendations for patient selection and monitoring. The Lancet neurology, Vol. 10, H. 8. pp. 745-758.

Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213.

Sombekke, M. H. and Jafari, N. and Bendfeldt, K. and Mueller-Lenke, N. and Radue, E. W. and Naegelin, Y. and Kappos, L. and Matthews, P. M. and Polman, C. H. and Barkhof, F. and Hintzen, R. and Geurts, J. J. G.. (2011) No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology, Vol. 76, H. 21. pp. 1843-1845.

Montalban, X. and Comi, G. and O'Connor, P. and Gold, Sm and de Vera, A. and Eckert, B. and Kappos, L.. (2011) Oral fingolimod (FTY720) in relapsing multiple sclerosis : impact on health-related quality of life in a phase II study. Multiple Sclerosis Journal, 17 (11). pp. 1341-1350.

Katan, M. and Nigro, N. and Fluri, F. and Schuetz, P. and Morgenthaler, N. G. and Jax, F. and Meckel, S. and Gass, A. and Bingisser, R. and Steck, A. and Kappos, L. and Engelter, S. and Müller, B. and Christ-Crain, M.. (2011) Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology, Vol. 76, H. 6. pp. 563-566.

2010

Mesaros, S. and Rocca, Ma and Sormani, Mp and Valsasina, P. and Markowitz, C. and De Stefano, N. and Montalban, X. and Barkhof, F. and Ranjeva, Jp and Sailer, M. and Kappos, L. and Comi, G. and Filippi, M.. (2010) Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis : a 14-month, multicentre, follow-up study. Multiple Sclerosis Journal, 16 (3). pp. 325-331.

Sahraian, M. A. and Radue, E.-W. and Haller, S. and Kappos, L.. (2010) Black holes in multiple sclerosis : definition, evolution, and clinical correlations. Acta neurologica scandinavica, Vol. 122, H. 1. pp. 1-8.

van den Elskamp, I. J. and Boden, B. and Dattola, V. and Knol, D. L. and Filippi, M. and Kappos, L. and Fazekas, F. and Wagner, K. and Pohl, C. and Sandbrink, R. and Polman, C. H. and Uitdehaag, B. M. J. and Barkhof, F.. (2010) Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology, Vol. 52, H. 10. pp. 875-881.

Morrow, S. A. and O'Connor, P. W. and Polman, C. H. and Goodman, A. D. and Kappos, L. and Lublin, F. D. and Rudick, R. A. and Jurgensen, S. and Paes, D. and Forrestal, F. and Benedict, R. H. B.. (2010) Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Multiple Sclerosis Journal, 16 (11). pp. 1385-1392.

van den Elskamp, I. J. and Knol, D. L. and Vrenken, H. and Karas, G. and Meijerman, A. and Filippi, M. and Kappos, L. and Fazekas, F. and Wagner, K. and Pohl, C. and Sandbrink, R. and Polman, C. H. and Uitdehaag, B. M. J. and Barkhof, F.. (2010) Lesional magnetization transfer ratio : a feasible outcome for remyelinating treatment trials in multiple sclerosis. Multiple Sclerosis Journal, 16 (6). pp. 660-669.

Bendfeldt, K. and Kappos, L. and Radue, E. W. and Borgwardt, S.. (2010) Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis. American journal of neuroradiology, Vol. 31, H. 5 , E45.

Lövblad, K.-O. and Anzalone, N. and Dörfler, A. and Essig, M. and Hurwitz, B. and Kappos, L. and Lee, S.-K. and Filippi, M.. (2010) MR imaging in multiple sclerosis : review and recommendations for current practice. American journal of neuroradiology, Vol. 31, H. 6. pp. 983-989.

Montalban, X. and Tintoré, M. and Swanton, J. and Barkhof, F. and Fazekas, F. and Filippi, M. and Frederiksen, J. and Kappos, L. and Palace, J. and Polman, C. and Rovaris, M. and de Stefano, N. and Thompson, A. and Yousry, T. and Rovira, A. and Miller, D. H.. (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology, Vol. 74, H. 5. pp. 427-434.

Grossman, P. and Kappos, L. and Gensicke, H. and D'Souza, M. and Mohr, D. C. and Penner, I. K. and Steiner, C.. (2010) MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology : journal of the American Academy of Neurology, Vol. 75, H. 13. pp. 1141-1149.

Comi, G. and O'Connor, P. and Montalban, X. and Antel, J. and Radue, E.-W. and Karlsson, G. and Pohlmann, H. and Aradhye, S. and Kappos, L.. (2010) Phase II study of oral fingolimod (FTY720) in multiple sclerosis : 3-year results. Multiple Sclerosis Journal, 16 (2). pp. 197-207.

Mehling, M. and Lindberg, R. and Raulf, F. and Kuhle, J. and Hess, C. and Kappos, L. and Brinkmann, V.. (2010) Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology, Vol. 75, H. 5. pp. 403-410.

2009

O'Connor, Paul and Filippi, Massimo and Arnason, Barry and Comi, Giancarlo and Cook, Stuart and Goodin, Douglas and Hartung, Hans-Peter and Jeffery, Douglas and Kappos, Ludwig and Boateng, Francis and Filippov, Vitali and Groth, Maria and Knappertz, Volker and Kraus, Christian and Sandbrink, Rupert and Pohl, Christoph and Bogumil, Timon and O'Connor, P. and Filippi, M. and Arnason, B. and Cook, S. and Goodin, D. and Harung, H.-P. and Kappos, L. and Jeffery, D. and Comi, G.. (2009) 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. The Lancet neurology, Vol. 8. pp. 889-897.

Palmowski-Wolfe, A. M. and Kappos, L. and Müller-Brand, J. and Buitrago-Tellez, C. and Merlo, A.. (2009) Belastungsabhängige vertikale Doppelbilder und Ptosis. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Vol. 106. pp. 52-55.

Baranzini, S. E. and Wang, J. and Gibson, R. A. and Galwey, N. and Naegelin, Y. and Barkhof, F. and Radue, E. W. and Lindberg, R. L. and Uitdehaag, B. M. and Johnson, M. R. and Angelakopoulou, A. and Hall, L. and Richardson, J. C. and Prinjha, R. K. and Gass, A. and Geurts, J. J. and Kragt, J. and Sombekke, M. and Vrenken, H. and Qualley, P. and Lincoln, R. R. and Gomez, R. and Caillier, S. J. and George, M. F. and Mousavi, H. and Guerrero, R. and Okuda, D. T. and Cree, B. A. and Green, A. J. and Waubant, E. and Goodin, D. S. and Pelletier, D. and Matthews, P. M. and Hauser, S. L. and Kappos, L. and Polman, C. H. and Oksenberg, J. R.. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 767-778.

Kuhle, J. and Lindberg, R. L. P. and Regeniter, A. and Mehling, M. and Steck, A. J. and Kappos, L. and Czaplinski, A.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology, Vol. 16. pp. 771-774.

O'Connor, P. and Comi, G. and Montalban, X. and Antel, J. and Radue, E. W. and de Vera, A. and Pohlmann, H. and Kappos, L.. (2009) Oral fingolimod (FTY720) in multiple sclerosis : two-year results of a phase II extension study. Neurology : journal of the American Academy of Neurology, Vol. 72. pp. 73-79.

Bendfeldt, K. and Radue, E. W. and Borgwardt, S. J. and Kappos, L.. (2009) Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. Journal of the neurological sciences, Vol. 285, No. 1-2 , S. 268-269 ; author reply 269.

Mehta, L. R. and Schwid, S. R. and Arnold, D. L. and Cutter, G. R. and Aradhye, S. and Balcer, L. J. and Calabresi, P. A. and Cohen, J. A. and Cole, P. E. and Glanzman, R. and Goelz, S. and Inglese, M. and Kapoor, R. and Kappos, L. and Kreitman, R. and Lublin, F. D. and Mann, A. and Marrie, R. A. and O'Looney, P. and Polman, C. H. and Ravina, B. M. and Reingold, S. C. and Richert, J. R. and Sandrock, A. W. and Waubant, E.. (2009) Proof of concept studies for tissue-protective agents in multiple sclerosis. Multiple Sclerosis Journal, 15 (5). pp. 542-546.

Gugleta, K. and Kochkorov, A. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Retinal vessels in patients with multiple sclerosis : baseline diameter and response to flicker light stimulation. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 272-275.

Kochkorov, A. and Gugleta, K. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Rigidity of retinal vessels in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 276-279.

Mancini, L. and Ciccarelli, O. and Manfredonia, F. and Thornton, J. S. and Agosta, F. and Barkhof, F. and Beckmann, C. and De Stefano, N. and Enzinger, C. and Fazekas, F. and Filippi, M. and Gass, A. and Hirsch, J. G. and Johansen-Berg, H. and Kappos, L. and Korteweg, T. and Manson, S. C. and Marino, S. and Matthews, P. M. and Montalban, X. and Palace, J. and Polman, C. and Rocca, M. and Ropele, S. and Rovira, A. and Wegner, C. and Friston, K. and Thompson, A. and Yousry, T.. (2009) Short-term adaptation to a simple motor task : a physiological process preserved in multiple sclerosis. NeuroImage : a journal of brain function, Vol. 45. pp. 500-511.

Reingold, S. C. and Steiner, J. P. and Polman, C. H. and Cohen, J. A. and Freedman, M. S. and Kappos, L. and Thompson, A. J. and Wolinsky, J. S.. (2009) The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology, Vol. 73, H. 7. pp. 552-559.

Penner, I. K. and Raselli, C. and Stöcklin, M. and Opwis, K. and Kappos, L. and Calabrese, P.. (2009) The fatigue scale for motor and cognitive functions (FSMC) : validation of a new instrument to assess multiple sclerosis-related fatigue. Multiple Sclerosis Journal, 15 (12). pp. 1509-1517.

2008

Goodin, D. S. and Cohen, B. A. and O'Connor, P. and Kappos, L. and Stevens, J. C. and Therapeutics, and Technology, Assessment Subcommittee of the American Academy of Neurology. (2008) Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, Vol. 71, H. 10. pp. 766-773.

Vogt, A. and Kappos, L. and Stöcklin, M. and Gschwind, L. and Opwis, K. and Penner, I. -K.. (2008) BrainStim : Wirksamkeit eines neu entwickelten kognitiven Traningsprogramms bei MS. Neurologie & Rehabilitation, Vol. 14. pp. 95-103.

Miller, D. H. and Weinshenker, B. G. and Filippi, M. and Banwell, B. L. and Cohen, J. A. and Freedman, M. S. and Galetta, S. L. and Hutchinson, M. and Johnson, R. T. and Kappos, L. and Kira, J. and Lublin, F. D. and McFarland, H. F. and Montalban, X. and Panitch, H. and Richert, J. R. and Reingold, S. C. and Polman, C. H.. (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis Journal, 14 (9). pp. 1157-1174.

Calabrese, P. and Schlegel, U. and Kappos, L. and Opwis, K. and Penner, I. -K.. (2008) Effects of medication and cognitive training on alertness function in patients with multiple sclerosis. Journal of neurology, Vol. 255, Suppl. 2. pp. 81-82.

Kappos, L. and Gold, R. and Miller, D. H. and Macmanus, D. G. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Yang, M. and Eraksoy, M. and Meluzinova, E. and Rektor, I. and Dawson, K. T. and Sandrock, A. W. and O'Neill, G. N.. (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, Vol. 372. pp. 1463-1472.

Polman, C. H. and Reingold, S. C. and Barkhof, F. and Calabresi, P. A. and Clanet, M. and Cohen, J. A. and Cutter, G. R. and Freedman, M. S. and Kappos, L. and Lublin, F. D. and McFarland, H. F. and Metz, L. M. and Miller, A. E. and Montalban, X. and O'Connor, P. W. and Panitch, H. and Richert, J. R. and Petkau, J. and Schwid, S. R. and Sormani, M. P. and Thompson, A. J. and Weinshenker, B. G. and Wolinsky, J. S.. (2008) Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology, Vol. 70, H. 13, Pt. 2. pp. 1134-1140.

Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. pp. 1261-1267.

Manson, S. C. and Wegner, C. and Filippi, M. and Barkhof, F. and Beckmann, C. and Ciccarelli, O. and De Stefano, N. and Enzinger, C. and Fazekas, F. and Agosta, F. and Gass, A. and Hirsch, J. and Johansen-Berg, H. and Kappos, L. and Korteweg, T. and Polman, C. and Mancini, L. and Manfredonia, F. and Marino, S. and Miller, D. H. and Montalban, X. and Palace, J. and Rocca, M. and Ropele, S. and Rovira, A. and Smith, S. and Thompson, A. and Thornton, J. and Yousry, T. and Frank, J. A. and Matthews, P. M.. (2008) Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Experimental brain research, Vol. 187. pp. 25-31.

Fox, R. J. and Kappos, L.. (2008) Is natalizumab overshooting its rebound? Neurology, Vol. 70, H. 13, Pt. 2. pp. 1073-1074.

Lindberg, R. L. and Achtnichts, L. and Hoffmann, F. and Kuhle, J. and Kappos, L.. (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of neuroimmunology, Vol. 194. pp. 153-164.

Engelhardt, B. and Kappos, L.. (2008) Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neuro-degenerative Diseases, 5 (1). pp. 16-22.

Ehrensperger, M. M. and Grether, A. and Romer, G. and Berres, M. and Monsch, A. U. and Kappos, L. and Steck, B.. (2008) Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis. Multiple Sclerosis Journal, 14 (8). pp. 1106-1112.

Weier, K. and Naegelin, Y. and Thoeni, A. and Hirsch, J. G. and Kappos, L. and Steinbrich, W. and Radue, E. W. and Gass, A.. (2008) Non-communicating syringomyelia : a feature of spinal cord involvement in multiple sclerosis. Brain, Vol. 131, H. 7. pp. 1776-1782.

Gugleta, K. and Mehling, M. and Kochkorov, A. and Grieshaber, M. and Katamay, R. and Flammer, J. and Orgül, S. and Kappos, L.. (2008) Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 225, H. 5. pp. 408-412.

Farrell, R. and Bendtzen, K. and Bertolotto, A. and Clark, B. and Comabella, M. and Deisenhammer, F. and Fogdell-Hahn, A. and Giovannoni, G. and Hartung, H. P. and Hemmer, B. and Hillert, J. and Kappos, L. and Killestein, J. and Lindberg, R. and Montalban, X. and Polman, C. and Sorensen, P. S. and European, Nabinms Consortium. (2008) Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of international medical research, Vol. 36, H. 1 , S. 204-208 ; author reply 208-210.

D'Souza, M. and Kappos, L. and Czaplinski, A.. (2008) Reconsidering clinical outcomes in Multiple Sclerosis : relapses, impairment, disability and beyond. Journal of the neurological sciences, Vol. 274, No. 1-2. pp. 76-79.

Bosnell, R. and Wegner, C. and Kincses, Z. T. and Korteweg, T. and Agosta, F. and Ciccarelli, O. and De Stefano, N. and Gass, A. and Hirsch, J. and Johansen-Berg, H. and Kappos, L. and Barkhof, F. and Mancini, L. and Manfredonia, F. and Marino, S. and Miller, D. H. and Montalban, X. and Palace, J. and Rocca, M. and Enzinger, C. and Ropele, S. and Rovira, A. and Smith, S. and Thompson, A. and Thornton, J. and Yousry, T. and Whitcher, B. and Filippi, M. and Matthews, P. M.. (2008) Reproducibility of fMRI in the clinical setting: implications for trial designs. NeuroImage, Vol. 42, H. 2. pp. 603-610.

Polman, C. and Kappos, L. and Freedman, M. S. and Edan, G. and Hartung, H. P. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Selmaj, K. and Uitdehaag, B. M. and Dahms, S. and Bauer, L. and Pohl, C. and Sandbrink, R. and Benefit, investigators. (2008) Subgroups of the BENEFIT study : risk of developing MS and treatment effect of interferon beta-1b. Journal of neurology, Vol. 255, H. 4. pp. 480-487.

Oestmann, A. and Achtnichts, L. and Kappos, L. and Gass, A. and Naegelin, Y.. (2008) ["Numb chin syndrome": first presenting syndrome of multiple sclerosis?]. Deutsche medizinische Wochenschrift, Jg. 133, H. 3. pp. 76-78.

Sailer, M. and Fazekas, F. and Gass, A. and Kappos, L. and Radue, E. W. and Rieckmann, P. and Toyka, K. and Wiendl, H. and Bendszus, M.. (2008) [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]. RÖFO, Vol. 180, H. 11. pp. 994-1001.

2007

Calabrese, P. and De Vera, A. and Haupts, M. and Kappos, L. and Schlegel, U. and Radü, E. W. . and Opwis, K. and Penner, I. -K.. (2007) Alertness dysfunction in MS : structural lesions and functional consequences. Aktuelle Neurologie, Vol. 34, Suppl. 1 , S197.

Vogt, A. and Kappos, L. and Gschwind, L. and Opwis, K. and Radue, E. W. and Penner, I. K.. (2007) Effects of a new computerised working memory training in patients with multiple sclerosis. Multiple Sclerosis Journal, 13 (2_suppl). S235.

Penner, I.-K. and Bechtel, N. and Raselli, C. and Stöcklin, M. and Opwis, K. and Kappos, L. and Calabrese, P.. (2007) Fatigue in multiple sclerosis : relation to depression, physical impairment, personality and action control. Multiple Sclerosis Journal, 13 (9). pp. 1161-1167.

Penner, I. -K. and Opwis, K. and Kappos, L.. (2007) Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. Journal of neurology, Vol. 254, Suppl. 2. pp. 53-57.

Penner, I.-K. and Raselli, C. and Stoecklin, M. and Opwis, K. and Kappos, L.. (2007) The FSMC (Fatigue scale for motor and cognitive functions) : a new instrument to assess MS-related fatigue. Multiple Sclerosis Journal, 13 (2_suppl). S238.

Penner, I. -K. and Raselli, C. and Stöcklin, M. and Opwis, K. and Kappos, L.. (2007) The FSMC (fatigue scale for motor and cognitive functions) : a new instrument to assess MS related fatigue in clinical routine. European journal of neurology, Vol. 14, Suppl. 1. p. 275.

Penner, I. -K. and Raselli, C. and Stöcklin, M. and Opwis, K. and Kappos, L.. (2007) The fatigue scale for motor and cognitive functions : a recently validate instrument to assess MS-related fatigue : abstract. Aktuelle Neurologie, Vol. 34, Suppl. 1 , S49.

2006

Vogt, A. and Kappos, L. and Opwis, K. and Radu, E. W. and Penner, I. K.. (2006) Computer-based working memory training in patients with multiple sclerosis : design of a randomised study. Multiple Sclerosis Journal, 12 (1_suppl). S142.

Penner, I. K. and Raselli, C. and Stocklin, M. and Opwis, K. and Kappos, L. and Fsmc Study Group, . (2006) The FSMC (Fatigue Scale for Motor and Cognitive functions) : first results from a multicentre validation study on a new patient reported outcome measure for cognitive and motor fatigue in multiple sclerosis. Multiple Sclerosis Journal, 12 (1_suppl). S151-S152.

Penner, I. -K. and Kappos, L. and Rausch, M. and Opwis, K. and Radü, E. W.. (2006) Therapy-induced plasticity of cognitive functions in MS patients : insights from fMRI. Journal of physiology - Paris, Vol. 99. pp. 455-462.

2005

Penner, I. -K. and Kappos, L. and Opwis, K.. (2005) Induced changes in brain activation using a computerized attention training in patients with Multiple Sclerosis (MS). In: Proceedings of KogWis05. Basel, pp. 150-154.

Penner, I. K. and Vogt, A. and Raselli, C. and Stocklin, M. and Opwis, K. and Kappos, L.. (2005) The FSMC (Fatigue Scale for Motor and Cognitive Functions) : a new patient-reported outcome measure for cognitive and motor fatigue in multiple sclerosis. Multiple Sclerosis Journal, 11 (5_suppl). S66.

2004

Penner, I. -K. and Hardmeier, M. and Vogt, A. and Stoecklin, M. and Raselli, C. and Opwis, K. and Radue, E. W. and Kappos, L.. (2004) Experimentally induced fatigue in MS patients. Multiple sclerosis, Vol. 10, no. 7032, Suppl. 2 , S126-S127.

Penner, I. -K. and Rausch, M. and Kappos, L. and Opwis, K. and Radü, E. W.. (2004) Funktionelle Bildgebung bei Multipler Sklerose. In: Bildgebung in der klinischen Neuroimmunologie. Stuttgart, pp. 57-64.

Penner, I. -K. and De Vera, A. and Kappos, L. and Opwis, K. and Radü, E. W.. (2004) Kognitive Störungen bei Multipler Sklerose : strukturelle und funktionelle Veränderungen als Erklärungsmodell? In: 44. Kongress der Deutschen Gesellschaft für Psychologie. Lengerich, p. 313.

2003

Penner, I. -K. and Rausch, M. and Kappos, L. and Opwis, K. and Radü, E. W.. (2003) Analysis of impairment related functional architecture in MS patients during performance of different attention tasks. Journal of neurology, Vol. 250, H. 4. pp. 461-472.

Penner, I. -K. and Rausch, M. and Kappos, L. and Opwis, K. and Radü, E. W.. (2003) Neurorehabilitation in Multiple Sclerosis : does functional MRI allow inferences about effectiveness? Journal of the International Neuropsychological Society, Vol. 9. p. 559.

2002

Penner, I. -K. and Rausch, M. and Opwis, K. and Kappos, L. and Radü, E. W.. (2002) Effects of cognitive training in MS patients visualized by functional MRI. In: 43. Kongress der Deutschen Gesellschaft für Psychologie. Lengerich, p. 233.

2001

Penner, I. -K. and Rausch, M. and Hardmeier, M. and Opwis, K. and Kappos, L. and Radü, E. W.. (2001) Altered functional activation in MS patients with reduced attentional performance demonstrated with functional MRI. NeuroImage, Vol. 13. p. 347.

Penner, I. -K. and Rausch, M. and Kappos, L. and Opwis, K. and Radü, E. W.. (2001) Does altered functional activation in MS patients reflect loss or presence of compensatory brain mechanisms? Multiple sclerosis, Vol. 7 , S13.

2000

Haselhorst, R. and Kappos, L. and Bilecen, D. and Scheffler, K. and Mori, D. and Radu, E. W. and Seelig, J.. (2000) Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis : application of an extended blood-brain barrier leakage correction. Journal of Magnetic Resonance Imaging, 11 (5). pp. 495-505.

Mader, I. and Roser, W. and Kappos, L. and Hagberg, G. and Seelig, J. and Radue, E. W. and Steinbrich, W.. (2000) Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques : absolute metabolic values over 2 years during a clinical pharmacological study. American Journal of Neuroradiology, 21 (7). pp. 1220-1227.

1995

Roser, W. and Hagberg, G. and Mader, I. and Brunnschweiler, H. and Radue, E. W. and Seelig, J. and Kappos, L.. (1995) Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magnetic Resonance in Medicine, 33 (6). pp. 811-817.

This list was generated on Thu Mar 28 11:26:34 2024 CET.